Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease.
Sato M, Neufeld EB, Playford MP, Lei Y, Sorokin AV, Aponte AM, Freeman LA, Gordon SM, Dey AK, Jeiran K, Hamasaki M, Sampson ML, Shamburek RD, Tang J, Chen MY, Kotani K, Anderson JL, Dullaart RP, Mehta NN, Tietge UJ, Remaley AT.
Sato M, et al.
J Clin Invest. 2023 Sep 15;133(18):e165370. doi: 10.1172/JCI165370.
J Clin Invest. 2023.
PMID: 37471145
Free PMC article.